Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropeptides ; 58: 83-92, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26764217

ABSTRACT

The neuropeptide galanin is widely distributed in the central and peripheral nervous systems and part of a bigger family of bioactive peptides. Galanin exerts its biological activity through three G-protein coupled receptor subtypes, GAL1-3R. Throughout the last 20years, data has accumulated that galanin can have a neuroprotective effect presumably mediated through the activation of GAL1R and GAL2R. In order to test the pharmaceutical potential of galanin receptor subtype selective ligands to inhibit excitotoxic cell death, the GAL1R selective ligand M617 and the GAL2R selective ligand M1145 were compared to the novel GAL1/2R ligand M1154, in their ability to reduce the excitotoxic effects of intracerebroventricular injected kainate acid in rats. The peptide ligands were evaluated in vitro for their binding preference in a competitive (125)I-galanin receptor subtype binding assay, and G-protein signaling was evaluated using both classical signaling and a label-free real-time technique. Even though there was no significant difference in the time course or severity of the kainic acid induced epileptic behavior in vivo, administration of either M617 or M1154 before kainic acid administration significantly attenuated the neuronal cell death in the hippocampus. Our results indicate the potential therapeutic value of agonists selective for GAL1R in the prevention of neuronal cell death.


Subject(s)
Bradykinin/analogs & derivatives , Galanin/analogs & derivatives , Hippocampus/pathology , Neurons/metabolism , Neurons/pathology , Peptide Fragments/pharmacology , Receptor, Galanin, Type 1/metabolism , Receptor, Galanin, Type 2/metabolism , Animals , Bradykinin/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Cyclic AMP/metabolism , Galanin/pharmacology , Hippocampus/drug effects , Humans , Kainic Acid/toxicity , Ligands , Male , Neurons/drug effects , Protein Binding , Rats , Rats, Sprague-Dawley , Receptor, Galanin, Type 1/agonists , Receptor, Galanin, Type 2/agonists
2.
Addict Biol ; 20(4): 701-13, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25053279

ABSTRACT

Relapse represents one of the most significant problems in the long-term treatment of drug addiction. Cocaine blocks plasma membrane monoamine transporters and increases dopamine (DA) overflow in the brain, and DA is critical for the motivational and primary reinforcing effects of the drug as well as cocaine-primed reinstatement of cocaine seeking in rats, a model of relapse. Thus, modulators of the DA system may be effective for the treatment of cocaine dependence. The endogenous neuropeptide galanin inhibits DA transmission, and both galanin and the synthetic galanin receptor agonist, galnon, interfere with some rewarding properties of cocaine. The purpose of this study was to further assess the effects of galnon on cocaine-induced behaviors and neurochemistry in rats. We found that galnon attenuated cocaine-induced motor activity, reinstatement and DA overflow in the frontal cortex at a dose that did not reduce baseline motor activity, stable self-administration of cocaine, baseline extracellular DA levels or cocaine-induced DA overflow in the nucleus accumbens (NAc). Similar to cocaine, galnon had no effect on stable food self-administration but reduced food-primed reinstatement. These results indicate that galnon can diminish cocaine-induced hyperactivity and relapse-like behavior, possibly in part by modulating DA transmission in the frontal cortex.


Subject(s)
Cocaine/pharmacology , Coumarins/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Frontal Lobe/metabolism , Animals , Cocaine-Related Disorders/physiopathology , Cocaine-Related Disorders/prevention & control , Conditioning, Operant , Dopamine/metabolism , Drug-Seeking Behavior/drug effects , Eating/drug effects , Extinction, Psychological/drug effects , Galanin/antagonists & inhibitors , Male , Microdialysis , Motor Activity/drug effects , Nucleus Accumbens/metabolism , Rats, Sprague-Dawley , Recurrence , Reinforcement, Psychology , Self Administration
3.
Brain Res ; 1425: 90-7, 2011 Nov 24.
Article in English | MEDLINE | ID: mdl-22024546

ABSTRACT

We evaluated levels of exercise-induced brain-derived neurotrophic factor (BDNF) messenger RNA (mRNA) within the hippocampal formation in rats selectively bred for 1) high intrinsic (i.e., untrained) aerobic capacity (High Capacity Runners, HCR), 2) low intrinsic aerobic capacity (Low Capacity Runners, LCR), and 3) unselected Sprague-Dawley (SD) rats with or without free access to running wheels for 3 weeks. The specific aim of the study was to determine whether a dose-response relationship exists between cumulative running distance and levels of BDNF mRNA. No additional treatments or behavioral manipulations were used. HCR, LCR, and SD rats were grouped by strain and randomly assigned to sedentary or activity (voluntary access to activity wheel) conditions. Animals were killed after 21 days of exposure to the assigned conditions. Daily running distances (mean ± standard deviation meters/day) during week three were: HCR (4726 ± 3220), SD (2293 ± 3461), LCR (672 ± 323). Regardless of strain, levels of BDNF mRNA in CA1 were elevated in wheel runners compared to sedentary rats and this difference persisted after adjustment for age (p=0.040). BDNF mRNA was not affected by intrinsic aerobic capacity and was not related to total running distance. The results support that BDNF mRNA expression is increased by unlimited access to activity wheel running for 3 weeks but is not dependent upon accumulated running distance.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Breeding , Motor Activity/genetics , Physical Conditioning, Animal/physiology , RNA, Messenger/metabolism , Running/physiology , Age Factors , Animals , Brain-Derived Neurotrophic Factor/genetics , Breeding/methods , CA1 Region, Hippocampal/metabolism , Exercise Tolerance/genetics , Male , Physical Conditioning, Animal/methods , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley
4.
Am J Reprod Immunol ; 60(6): 541-55, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19032616

ABSTRACT

PROBLEM: Toll-like receptors (TLRs) are a family of innate immunity receptors that are essential for detecting invading pathogens. Objectives of this study were to identify epididymal cell types expressing TLRs and to determine if TLRs are present on spermatozoa. METHOD OF STUDY: Immunohistochemical analysis of paraffin-embedded sections from regions of the rat epididymis was used to identify epididymal cell types expressing TLRs. Immunoblot analysis and immunofluorescence were used to detect TLRs on spermatozoa. RESULTS: TLRs 1-9 and 11 are abundantly expressed by the epididymal epithelium in most regions of the duct with the exception of clear cells of the cauda which do not express TLRs 5-7 or 11. TLRs were detected on epididymal spermatozoa and several TLRs showed regional distributions patterns suggesting modification during epididymal transit. CONCLUSION: The abundance of TLR family members in the epididymal epithelium and on spermatozoa provides strong evidence that TLRs play important roles in innate immunity of the male reproductive tract.


Subject(s)
Epididymis/cytology , Epididymis/metabolism , Epithelial Cells/metabolism , Spermatozoa/metabolism , Toll-Like Receptors/metabolism , Animals , Immunohistochemistry , Male , Organ Specificity/immunology , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...